Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Next Generation Cancer Diagnostics Market to Reach $57.8 Billion by 2030
The global market for Next Generation Cancer Diagnostics estimated at US$6.7 Billion in the year 2022, is projected to reach a revised size of US$57.8 Billion by 2030, growing at a CAGR of 31% over the analysis period 2022-2030. qPCR & Multiplexing, one of the segments analyzed in the report, is projected to record 33% CAGR and reach US$25.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Next Generation Sequencing segment is readjusted to a revised 26.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 30.1% CAGR
The Next Generation Cancer Diagnostics market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world's second-largest economy, is forecast to reach a projected market size of US$9.9 Billion by the year 2030 trailing a CAGR of 30.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 27.9% and 26.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 21.5% CAGR.
Market Scope
The provided data encompasses a comprehensive analysis of the global next-generation cancer diagnostics market. It covers various geographic regions including the USA, Canada, Japan, China, Europe, Asia-Pacific, and the Rest of the World, and spans the years from 2014 to 2030.
The analysis includes insights into annual sales figures in US$ million and percentage CAGR for multiple technologies and applications such as qPCR & Multiplexing, Next Generation Sequencing, LOAC & RT-PCR, Other Technologies, Biomarker Development, CTC Analysis, Proteomic Analysis, Genetic Analysis, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis, and Other Applications.
Additionally, the 8-year perspective offers a percentage breakdown of value sales for the specified regions, highlighting trends and growth opportunities in the field of next-generation cancer diagnostics.
Market Overview
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Next Generation Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
What's New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Select Competitors (Total 33 Featured)
- Abbott
- Agilent Technologies
- Almac Group
- Cepheid
- F. Hoffmann-La Roche Ltd
- GE Healthcare
- Genomic Health
- Hologic
- Illumina
- Janssen Global Services
- Koninklijke Philips N.V
- Myriad Genetics
- Novartis AG
- Opko Health
- PerkinElmer
- Qiagen
- Sysmex Corporation
- Thermo Fisher Scientific
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $6.7 Billion |
| Forecasted Market Value (USD) by 2030 | $57.8 Billion |
| Compound Annual Growth Rate | 30.9% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/33cfco
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
